Results 21 to 30 of about 374,365 (198)
Cervical Secretions from Women After Depot Medroxyprogesterone Acetate (Depo-Provera) Administration Promote HIV Infectivity Ex Vivo [PDF]
VirusesDepot medroxyprogesterone acetate (Depo-Provera) has been associated with an increased risk of HIV acquisition. We have previously shown that Depo-Provera administration increases immune markers for HIV preference on peripheral and cervical CD4+ T cells ...
Carley Tasker +3 more
doaj +2 more sources
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
Open Access Journal of Contraception, 2016 Clarissa Lam,1 Amitasrigowri S Murthy2,3 1New York University School of Medicine, 2Department of Obstetrics and Gynecology, Bellevue Hospital Center, New York University School of Medicine, 3New York University Langone Medical Center, New York,
Lam C, Murthy AS
doaj +1 more source
Archives of Endocrinology and Metabolism, 2016 Objective The aim of this study was to evaluate for 12 months the changes of body weight using Depot Medroxyprogesterone Acetate (DMPA) and if these changes are related to inflammatory markers. Subjects and methods Twenty women of childbearing age who
Gisele Almeida Batista +6 more
doaj +2 more sources
Journal of Toxicology, 2016 A study was designed to investigate ameliorates effect of combined vitamins C and E able to against depot-medroxyprogesterone acetate- (DMPA-) induced ovarian oxidative stress in rat. Twenty-five female Wistar rats were divided into the following groups (
Atik Ismiyati +2 more
doaj +2 more sources
Depot medroxyprogesterone acetate discontinuation after weight gain in 17-19 year old adolescent girls [PDF]
, 2002 Depot medroxyprogesterone acetate (DMPA) is a long acting progesterone only contraceptive agent. Side effects such as irregular bleeding patterns and weight gain are attributed to discontinuation.
Church, Donna Lea
core +6 more sources
The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic. [PDF]
Obstet Gynecol, 2021 Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, health care professionals have made swift accommodations to provide consistent and safe care, including emphasizing remote access to allow physical distancing.
Burlando AM +6 more
europepmc +2 more sources
Effect of depot medroxyprogesterone acetate and testosterone oenanthate on serum lipoproteins in man
, 1990 Ten normal men were given three monthly intramuscular injections of 200mg of depot medroxyprogesterone acetate (DMPA) and 250mg of testosterone oenanthate (TE) as part of a male contraceptive trial.
Wallace, E M, Wu, F C
core +8 more sources
Frontiers in Reproductive Health, 2021 Introduction: Whether intramuscular depot medroxyprogesterone acetate (DMPA-IM) and norethisterone enanthate (NET-EN) have a differential impact on the incidence of sexually transmitted infection (STI) remains unclear.
Lisa M. Noguchi +11 more
doaj +1 more source
The Association Between Oral Contraceptives, Depot-Medroxyprogesterone Acetate, and Trichomoniasis [PDF]
, 2009 Hormonal contraception use by women may increase the risk of acquiring certain sexually transmitted infections. We explored the effect of hormonal contraceptive use, specifically oral contraception (OC), and depot-medroxyprogesterone acetate (DMPA) on ...
MacDonald, Pia D. M. +13 more
core +1 more source
Indonesian Journal of Obstetrics and Gynecology, 2014 Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone ...
Irwan Daido +2 more
doaj +1 more source